We are eager to answer them. Call us directly or submit the convenient online form below.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook
Baird Capital makes venture capital, growth equity and private equity investments in strategically targeted sectors around the world. Having invested in more than 275 companies over its history, Baird Capital partners with entrepreneurs and leverages its executive networks to strive to build exceptional companies. Baird Capital provides operational support to its portfolio companies through teams on the ground in Asia, a pro-active portfolio operations team and a deep network of relationships which together deliver enhanced shareholder value. Baird Capital is the direct private investment arm of Robert W. Baird & Co.
Tekla Capital Management (Formerly known as Hambrecht & Quist Capital Management LLC) is a registered investment adviser based in Boston, Massachusetts and is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.
Since 1991, Nitinol Devices & Components, Inc. (NDC) has been serving the medical device industry as a contract manufacturer with unsurpassed knowledge and experience. They are the most complete Nitinol development company servicing the medical device industry. NDC offers a single point of contact to ensure rapid response time and superior adaptability throughout the duration of their projects. They partner with their customers in material selection, component design, prototyping, process development, pilot production and full scale production. NDC provides a broad range of testing services including mechanical properties, corrosion, FEA, failure analysis and fatigue analysis. NDC has proven experience in supporting the needs of their customers in the following medical device categories: Endovascular, Peripheral Vascular, Neurovascular, Cardiovascular, and Orthopedic.
Volcano Capital invests in health care companies across a variety of asset classes including venture capital, public equities and debt. They provide funding and operational expertise to help entrepreneurs grow their healthcare businesses.
Prolog provides venture capital to Healthy Living entrepreneurs. They back innovations enhancing quality of life and offering effective ways to assess it. Their investment style is active, hands-on and focused on adding value. Prolog’s principals have a long history of collaboration as investors and business builders, with a track record at Prolog and several prior VC funds. Collectively, those funds secured in excess of $500 million in commitments and partnered with more than 100 companies.
Vectis Healthcare & Life Sciences Fund, II, L.P. (“Vectis II”) is a national life sciences venture capital and private equity fund that employs a hybrid strategy of fund and direct investments. Vectis II invests across all sub-sectors of the healthcare and life sciences industries, including plant sciences, biotechnology, medical technology, healthcare services, and health information technology. Co-headquartered in St. Louis and Boston, the fund’s co-General Partners are Stifel, Nicolaus & Company, Incorporated and Brooke Private Equity Associates.
CD-Venture, founded in 2003, is a company based in Heidelberg, Germany. They are focused on investments in the life science sector and support extraordinary ideas, entrepreneurs and technologies. Beside the financial support, they provide life science expertise and access to excellent international networks. Their portfolio includes early & late stage companies active in various areas of the life sciences like diagnostics, biopharmaceuticals, biotech, medical devices and healthcare IT in Europe and the USA.
Holton Capital Group is a St. Louis based family office investing in early stage technology and life science companies as well as later stage private equity buyouts and real estate. While their focus is on regional opportunities, they do work with various firms in the venture space in other markets. The majority of their early stage venture investing is made through Cultivation Capital and Prolog Ventures, both St. Louis based venture firms.
Established in January 2005, the St. Louis Arch Angels Network targets investments in the range of $250,000 to $1,000,000. Their 75+ members are all accredited investors from the St. Louis region. They have significant experience in a variety of fields as entrepreneurs, CEOs, venture capitalists and business leaders who have founded, funded and built companies. They mentor and coach the entrepreneurs they invest in; serving on their boards, providing contacts and assisting them with team building, strategic planning and fundraising. As of January 2014, the Arch Angel membership has invested over $40 million in 53 companies.
For Investor Relations
President & CEO
1610 Des Peres Road
St. Louis, MO 63131